Find generic entry opportunities
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Brinzolamide and brimonidine for treating ocular conditions|
|Abstract:||Methods and compositions for treating ocular conditions which find their etiology in compromised ocular blood flow with brinzolamide and brimonidine are disclosed.|
|Inventor(s):||Dean; Thomas R. (Weatherford, TX), Desantis, Jr.; Louis (Fort Worth, TX), York; Billie M. (Conroe, TX)|
|Assignee:||Alcon Laboratories, Inc. (Fort Worth, TX)|
|Filing Date:||Aug 04, 2000|
|Claims:||1. A method for treating ocular conditions selected from the group consisting of occlusion conditions, diabetic retinopathy, and neovascularization which comprises administering a pharmaceutically effective amount of brinzolamide and brimonidine. |
2. The method of claim 1 wherein the brinzolamide and brimonidine are dosed separately.
3. The method of claim 1 wherein the brinzolamide and the brimonidine are dosed simultaneously in a single formulation.
4. A composition for treating ocular conditions selected from the group consisting of occlusion conditions, diabetic retinopathy, and neovascularization comprising pharmaceutically effective amounts of brinzolamide and brimonidine.